Become A Featured Company

True Leaf Launches Crowdfunding Campaign

Ryan Allway

November 30th, 2017

Exclusive, News, Top News

There are many different ways that investors can participate in the cannabis industry’s tremendous growth, but True Leaf Medicine Inc. (CSE: MJ) (OTCQB: TRLFF) (FSE: TLA) represents one of the most interesting. In addition to its diverse exposure, both in terms of geography and end markets, the company’s Regulation A+ crowdfunding campaign, which launches today, November 30, enables investors to purchase equity in a unique way that provides benefits that aren’t typical for stocks purchased through a brokerage.

If you are interested in this investing opportunity, please visit invest.trueleaf.com.

Why Invest in True Leaf?

True Leaf Medicine Inc. is one of the only cannabis companies with federally legal products in both the United States and Canada. For investors, this translates to diversified exposure to the cannabis industry both in terms of geography and target markets. The company’s management team is confident in its future prospects with a nearly 40% stake in the company, which differs from many investment opportunities where management teams own a very little – or no – stake in the company. True Leaf’s Chairman of the Board, Michael Harcourt, is the former Premier of British Columbia and the former Mayor of Vancouver, lending a level of experience and gravitas unusual in the cannabis industry.

True Leaf Medicine

True Leaf Medicine was one of the earliest applicants to enter the process to become a licensed producer of medical cannabis under the ACMPR program. The company is currently in the final stages of the application and approval process. According to Deloitte, the country’s legal cannabis industry could be worth upwards of $22.6 billion following the legalization of both medical and recreational marijuana. Some companies and analysts believe that there could be a significant shortfall in production given the strong demand and bottleneck of suppliers.

Last month, the company acquired an option to purchase a 40-acre site in Lumby, British Columbia where it plans to retrofit an existing 16,000 square foot building to produce an initial 2,500 kilograms per year of dried cannabis. Management believes that this capacity could be expanded to a million square feet facility capable of producing 125,000 kilograms of dried cannabis per year, making it among the largest licensed producers. British Columbia is also becoming established as the “Napa Valley” of cannabis.

True Leaf Pet

True Leaf Pet was established in 2015 to pioneer and market hemp-focused products for the pet industry. After launching the True Hemp™ product line in Canada, the U.S., and Europe, the company become one of the first hemp-based pet product lines marketed worldwide. The APPA projects that pet spending in the U.S. alone will reach nearly $70 billion this year, including nearly $15 billion spent on pet supplies and over-the-counter supplements. Notably, the company’s products contain no CBD or THC, which makes them legal everywhere.

Last month, the company announced that it significantly expanded distribution of its True Hemp™ supplements both online and through brick-and-mortar stores. The supplements are now available for sale on Amazon.com, WholesalePet.com, and through more than 400 specialty Pet Supplies Plus stores. This extensive distribution across more than 1,600 stores in the United States sets it apart from many competitors that have only a small online presence in the market and limited sales over a short lifespan

Benefits of Crowdfunding

True Leaf Medicine Inc. already trades on the Canadian Stock Exchange under the ticker symbol “MJ”, but in the United States, it’s looking to raise $10 million in a Regulation A+ crowdfunding campaign. Under the offering, investors would be able to purchase a stake in the company for as little as C$350 and become one of the first investors in a crowdfunding campaign focused on the cannabis industry, with free trading shares not subject to escrow.

The company benefits from a longer-term shareholder base that is less likely to sell equity in the short-term, as well as the lighter regulatory requirements associated with Regulation A+ versus listing on a U.S. stock exchange. Investors benefit from unique rewards that aren’t possible using traditional stock brokerages, including free trading shares, special shout outs, discounts, products, and much more, according to the company.

Looking Ahead

True Leaf Medicine Inc. (CSE: MJ) (OTCQB: TRLFF) (FSE: TLA) represents a compelling investment opportunity in the cannabis industry given its diverse exposure in terms of geography and end markets. Investors interested in the company may want to consider its Regulation A+ offering as a compelling way to invest given the ancillary benefits and advantages to the company.

If you are interested in this investing opportunity, please visit invest.trueleaf.com.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading